Teneligliptin

Chemical formula: C₂₂H₃₀N₆OS  Molecular mass: 426.22 g/mol  PubChem compound: 11949652

Therapeutic indications

Teneligliptin is indicated for:

Type 2 diabetes mellitus

Population group: only adults (18 years old or older)

Teneligliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Usually, teneligliptin is used as monotherapy in patients for whom metformin is inappropriate due to contraindications or intolerance. Further, teneligliptin can also be used in combination with metformin or other antidiabetic medications.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Teneligliptin is contraindicated in the following cases:

Lactation

Lactation

Type 1 diabetes

Diabetes mellitus type I

Diabetic coma, history of diabetic coma

† Diabetic coma

Severe ketosis

Ketosis

Severe infection, surgery, trauma

at least one of
Infectious disease
Surgical procedure
Traumatic injury

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Medication Package Insert (MPI) 2021: TENEBLU Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈